NICE (UK National Institute for Clinical Excellence) boosts capacity ahead of new, enlarged agenda
This article was originally published in Clinica
The UK's Department of Health (DoH) has announced the technologies it will next submit to the National Institute for Clinical Excellence (NICE), subject to consultation with key stakeholders. Meanwhile, NICE has amended its appraisals process and is strengthening its capacity, ahead of a possible doubling of its workload.
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.